Technical Analysis for MYOK - MyoKardia, Inc.

Grade Last Price % Change Price Change
grade B 61.32 6.00% 3.47
MYOK closed up 6.0 percent on Friday, September 20, 2019, on 4.19 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical MYOK trend table...

Date Alert Name Type % Chg
Expansion Breakout Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%

Older signals for MYOK ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
MyoKardia, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small molecule that is in three Phase I clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy (HCM). The company also develops DCM-1, a product candidate that treats heritable dilated cardiomyopathy (DCM) by restoring normal contractility in the diseased DCM heart. In addition, it develops HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients; and LUS-1, a product candidate, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart. MyoKardia, Inc. has a strategic collaboration with Sanofi S.A. The company was founded in 2012 and is headquartered in South San Francisco, California.
Medical Specialties Anatomy Sports Medicine Cardiomyopathy Muscular System
Is MYOK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 67.78
52 Week Low 39.01
Average Volume 260,514
200-Day Moving Average 49.5237
50-Day Moving Average 53.5986
20-Day Moving Average 53.6085
10-Day Moving Average 55.209
Average True Range 2.5531
ADX 13.38
+DI 31.7911
-DI 14.1043
Chandelier Exit (Long, 3 ATRs ) 54.1707
Chandelier Exit (Short, 3 ATRs ) 57.3493
Upper Bollinger Band 58.7234
Lower Bollinger Band 48.4936
Percent B (%b) 1.25
BandWidth 19.082422
MACD Line 1.1995
MACD Signal Line 0.4508
MACD Histogram 0.7487
Fundamentals Value
Market Cap 1.93 Billion
Num Shares 31.5 Million
EPS -0.65
Price-to-Earnings (P/E) Ratio -94.34
Price-to-Sales 26.88
Price-to-Book 9.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 68.04
Resistance 3 (R3) 67.46 64.65 66.92
Resistance 2 (R2) 64.65 62.94 64.94 66.55
Resistance 1 (R1) 62.98 61.88 63.82 63.56 66.17
Pivot Point 60.17 60.17 60.58 60.46 60.17
Support 1 (S1) 58.50 58.46 59.34 59.08 56.47
Support 2 (S2) 55.69 57.40 55.98 56.09
Support 3 (S3) 54.02 55.69 55.72
Support 4 (S4) 54.60